KRAS G12D solid tumoursPhase 1NCT06040541Papers
RAS(ON) G12D inhibitor
A molecular-glue inhibitor that goes after GTP-bound KRAS G12D — the “on” state — rather than the inactive GDP-bound form.
1 Phase 1 study recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Solid tumors and other cancers1 study
KRAS G12D solid tumoursPhase 1NCT06040541Papers
A molecular-glue inhibitor that goes after GTP-bound KRAS G12D — the “on” state — rather than the inactive GDP-bound form.